α2A-Adrenergic Receptor Inhibits the Progression of Cervical Cancer Through Blocking PI3K/AKT/mTOR Pathway

OBJECTIVE: The study aimed to investigate the effect of α2A-adrenergic receptor (ADRA2A) on cervical cancer and the potential mechanisms of ADRA2A on phosphatidylinositol 3′-kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway in cervical cancer cells. METHODS: In our study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Weina, Guo, Xin, Dan, Huiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574911/
https://www.ncbi.nlm.nih.gov/pubmed/33116632
http://dx.doi.org/10.2147/OTT.S264409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574911/
https://www.ncbi.nlm.nih.gov/pubmed/33116632
http://dx.doi.org/10.2147/OTT.S264409

Ejemplares similares